ADAG

Adagene Inc

PHARMACEUTICAL PREPARATIONS
LIFE SCIENCES

Prices are adjusted according to historical splits.

Adagene Inc Stock Price

Vitals

Today's Low:
$0.9001
Today's High:
$1.0000
Open Price:
$0.9499
52W Low:
$0.9
52W High:
$12
Prev. Close:
$0.9499
Volume:
25808

Company Statistics

Market Cap.:
$0.040 billion
Book Value:
2.595
Revenue TTM:
$0.013 billion
Operating Margin TTM:
-651%
Gross Profit TTM:
$0.010 billion
Gross Profit TTM:
$0.010 billion
Profit Margin:
0%
Return on Assets TTM:
-26.2%
Return on Equity TTM:
-56%

Company Profile

Adagene Inc had its IPO on 2021-02-09 under the ticker symbol ADAG.

The company operates in the LIFE SCIENCES sector and PHARMACEUTICAL PREPARATIONS industry. Adagene Inc has a staff strength of 0 employees.

Stock update

Shares of Adagene Inc opened at $0.95 at the start of the last trading session i.e. 2022-11-02.

The stocks traded within a range of $0.9 - $1, and closed at $0.92.

This is a -3.12% slip from the previous day's closing price.

A total volume of 25,808 shares were traded at the close of the day’s session.

In the last one week, shares of Adagene Inc have slipped by -7.97%.

Adagene Inc's Key Ratios

Adagene Inc has a market cap of $0.040 billion, indicating a price to book ratio of 0.347 and a price to sales ratio of 3.137.

In the last 12-months Adagene Inc’s revenue was $0.013 billion with a gross profit of $0.010 billion and an EBITDA of $-0.082 billion. The EBITDA ratio measures Adagene Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Adagene Inc’s operating margin was -651% while its return on assets stood at -26.2% with a return of equity of -56%.

In Q2, Adagene Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 188.7%.

Adagene Inc’s PE and PEG Ratio

Forward PE
-
Trailing PE
-
PEG
None

Its diluted EPS in the last 12-months stands at $-1.829 per share while it has a forward price to earnings multiple of - and a PEG multiple of None. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Adagene Inc’s profitability.

Adagene Inc stock is trading at a EV to sales ratio of 0.0853 and a EV to EBITDA ratio of 1.382. Its price to sales ratio in the trailing 12-months stood at 3.137.

Adagene Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$0.000 billion
Total Liabilities
$0.000 billion
Operating Cash Flow
$0.000 billion
Capital Expenditure
$0.000 billion
Dividend Payout Ratio
0%

Adagene Inc ended 1970 with $0.000 billion in total assets and $131.2 billion in total liabilities. Its intangible assets were valued at $0.000 billion while shareholder equity stood at $0.000 billion.

Adagene Inc ended 1970 with $0.000 billion in deferred long-term liabilities, $0.000 billion in other current liabilities, billion in common stock, $0.000 billion in retained earnings and $0.000 billion in goodwill. Its cash balance stood at $0.000 billion and cash and short-term investments were $0.000 billion. The company’s total short-term debt was $0.000 billion while long-term debt stood at $0.000 billion.

Adagene Inc’s total current assets stands at $0.000 billion while long-term investments were $0.000 billion and short-term investments were $0.000 million. Its net receivables were $0.000 billion compared to accounts payable of $0.000 billion and inventory worth $0.000 billion.

In 1970, Adagene Inc's operating cash flow was $0.000 billion while its capital expenditure stood at $0.000 billion.

Comparatively, Adagene Inc paid $0 billion in dividends in 1970.

Other key metrics

Current Trading Price
$0.92
52-Week High
$12
52-Week Low
$0.9
Analyst Target Price
$16.03

Adagene Inc stock is currently trading at $0.92 per share. It touched a 52-week high of $12 and a 52-week low of $12. Analysts tracking the stock have a 12-month average target price of $16.03.

Its 50-day moving average was $0 and 200-day moving average was $0 The short ratio stood at indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.

Frequently Asked Questions About Adagene Inc

The stock symbol (also called stock or share ticker) of Adagene Inc is ADAG

The IPO of Adagene Inc took place on 2021-02-09

Similar Industry Stocks (PHARMACEUTICAL PREPARATIONS)

Last Price
Chg
Chg%
$8.21
-2.7
-24.75%
Xencor Inc (XNCR)
$27.43
-0.84
-2.97%
$3.28
-0.07
-2.09%
$3.29
-0.03
-0.9%
$7.44
-0.32
-4.12%

Most Active

Last Price
Chg
Chg%
$58.63
-1.03
-1.73%
$92.12
-4.67
-4.82%
$5.12
-0.61
-10.65%
Apple Inc (AAPL)
$145.03
-5.62
-3.73%
$0.06
0.01
+12.74%

Top Gainers

Last Price
Chg
Chg%
$73
42.7
+140.92%
Oi S.A (OIBR-C)
$0
0
+100%
$0.02
0.01
+100%
$0.25
0.1
+66.44%
$2.85
1.01
+54.86%

Top Losers

Last Price
Chg
Chg%
$5.36
-22.58
-80.82%
$0.02
-0.06
-78.67%
Air T, Inc (AIRTW)
$0.01
-0.03
-75%
$4.51
-5.17
-53.41%
$11.5
-12.2
-51.48%

About

Adagene Inc., a clinical-stage biopharmaceutical company, is dedicated to the research, development, and production of monoclonal antibody drugs for cancer. The company is headquartered in Suzhou, China.

Address

4F, BUILDING C14, NO. 218, XINGHU STREET, SUZHOU INDUSTRIAL PARK, SUZHOU, CHINA